presentation1 ob =0
TRANSCRIPT
-
8/14/2019 Presentation1 OB =0
1/24
DIC in OBSTETRICS( Disseminated IntravascularCoagulation)
-
8/14/2019 Presentation1 OB =0
2/24
Definiton
-also known as consumptive coagulopathy
- a pathological activation ofcoagulation (blood clotting)mechanisms that happens in response to a variety ofdiseases which leads to the formation of thrombi in the
microvasculature of the body.
a complex systemic thrombohemorrhagic disorderinvolving the generation of intravascular fibrin and theconsumption of procoagulants and platelets, and also
because of systemic circulation of thrombin and plasminthat result to intravascular coagulation and hemorrhage.
-
8/14/2019 Presentation1 OB =0
3/24
OverviewDIC is a pathophysiological process and not a disease. It is
when the body's natural ability to regulate blood clotting doesnot function properly because of excessive consumption of
clotting factors and platelets within circulation.
This causes the blood's clotting cells (platelets) to clump
together and clog small blood vessels throughout the body.
This excessive clotting damages organs, destroys blood cells,
and depletes the supply of platelets and other clotting factors
so that the blood is no longer able to clot normally. This often
causes widespread bleeding, both internally and externally.
http://www.webmd.com/hw-popup/platelethttp://www.webmd.com/hw-popup/platelet -
8/14/2019 Presentation1 OB =0
4/24
Pathophysiology
Pregnancy Hypercoagulability
Pregnancy normally induces:
concentrations of coagulation factors I
(fibrinogen), VII, VIII, IX, X.
plasminogen levels
Plasma factors and platelets do not change
so remarkably.Plasmin is normally decreased.
-
8/14/2019 Presentation1 OB =0
5/24
Pathological activation of coagulation
I. Coagulation maybe activated via:
a. extrinsic pathway by thromboplastin from tissuedestruction
b. intrinsic pathway by collagen and other tissue
components when there is loss of endothelial
integrity.
II. Tissue factor is released and complexes with
factor VII, which in turn activates tenase (factor IX)
and prothrombinase (factor X) complexes.
-
8/14/2019 Presentation1 OB =0
6/24
Common inciting factors of DIC:
Thromboplastin, endotoxin and exotoxins
from placental abruption
Direct activation of factor X by proteases
Amniotic fluid contains abundant mucin
from fetal squames which causes rapiddefibrination with amniotic fluid embolism.
-
8/14/2019 Presentation1 OB =0
7/24
- Consumptive coagulopathy is almostalways seen as a complication of an
identifiable, underlying pathologicalprocess against which treatment must bedirected to reverse defibrination.
- With pathological activation of
procoagulants that trigger consumptivecoagulopathy, there is consumption ofplatelets and coagulation factors in variablequantities.
- As a consequence, fibrin may be depositedin small vessels of virtually every organssystem.
-
8/14/2019 Presentation1 OB =0
8/24
- Small vessels are protected becausecoagulation release fibrin monomers
that contain with tissue plasminogenactivator and plasminogen wichreleases plasmin.
- Plasmin lyses fibrinogen, fibrinmonomers, and fibrin polymers toform a series of fibrinogen-fibrinderivatives.
- Measured by immunoassay, theseare known as fibrin degradtionproducts as split products.
-
8/14/2019 Presentation1 OB =0
9/24
Conditions associated with DIC in
obstetrics
Abruptio placenta
Amniotic fluid embolism
Pre-eclampsia and eclampsiaabortion
-
8/14/2019 Presentation1 OB =0
10/24
Abruptio Placenta
Etiology:
the placenta breaks away, or abrupts, from the wall ofthe uterus too early, before the baby is born.
(http://www.webmd.com/baby/tc/placenta-abruptio-topic-overview)
The hypertensive states of pregnancy are associated
with 2.5 17.9% incidence of placental separation.
http://www.webmd.com/baby/tc/placenta-abruptio-topic-overviewhttp://www.webmd.com/baby/tc/placenta-abruptio-topic-overview -
8/14/2019 Presentation1 OB =0
11/24
Predisposing factors:
maternal age,
multiparty,
uterine distention (multiple gestation, hydramnios),
vascular disease (DM, SLE),
thrombophilias,uterine anomalies or tumors (leiomyoma),
cigarette smoking,
alcohol consumption (>14 drinks/day),
coccaine use,
possibly maternal type O blood
-
8/14/2019 Presentation1 OB =0
12/24
Amniotic fluid Embolism
a rare obstetric emergency in which it is postulated thatamniotic fluid, fetal cells, hair, or other debris enter thematernal circulation, causing cardiorespiratory collapse.
(http://emedicine.medscape.com/article/253068-overview)
The etiology of coagulopathy associated with amnioticfluid embolism is incompletely understood, but it isknown that amniotic fluid has a potent totalthromboplastin and antifibrinolytic activity. Both of which
increase with advancing gestational age.
The response to amniotic fluid embolus in humans maybe biphasic, initially resulting in intense vasospasm,severe pulmonary hypertension, and hypoxia
-
8/14/2019 Presentation1 OB =0
13/24
Pre-eclampsia and Eclampsia
Preeclampsia usually occurs with first pregnancies.
May be seen:
with twins (or multiple pregnancies)
in women older than 35 years,
in women with high blood pressure before pregnancy,
in women with diabetes
in women with other medical problems (such as
connective tissue disease and kidney disease).
-
8/14/2019 Presentation1 OB =0
14/24
Preeclampsia is also associated with:
problems with the placenta (such as too much
placenta, too little placenta)
how the placenta attaches to the wall of the uterus.
hydatidiform mole pregnancies
-
8/14/2019 Presentation1 OB =0
15/24
Abortion
- Serious disruption of the coagulation mechanism as theconsequence of abortion may develop in the folowing:
Prolonged retention of a dead fetus
Sepsis syndrome Medical induction with prostaglandin During instrumental termination of the pregnancy Intrauterine instillation of hypertonic saline or urea
solutions
thromboplastin is released from the placenta, fetus anddecidua because of the necrobiotic effect of the hypertonicsolutions, which then initiates coagulation within thematernal circulation.
-
8/14/2019 Presentation1 OB =0
16/24
Clinical features presentation in pregnancy may be more
sudden and unexpected causing:> Generalized bleeding> Localized hemorrhage> Purpura> Petechiae
> Fever> Hypertension> Proteinuria> Hypoxia
Widespread fibrin deposition may affect lungs,brain, kidney, liver Chronic DIC may have minimal or absentclinical signs and symptoms
-
8/14/2019 Presentation1 OB =0
17/24
Prognosis
- The likelihood of life threatening hemorrhages in
obstetrical situations complicated by consumptive
coagulopathy depends not only on the extent of
coagulation defects but on whether the
vasculature is intact or ruptured
- With gross derrangement of blood coagulation,
there maybe fatal hemorrhage when vascular
integrity is disrupted yet no hemorrhage as long as
all blood vessels remain intact.
-
8/14/2019 Presentation1 OB =0
18/24
Diagnostic Procedures
D-dimer test. This blood test helps determine whether a person's blood
is clotting normally by measuring a substance (fibrin)
Prothrombin time (PT/INR). This blood test measures how long it takes
blood to clot.
Fibrinogen. This blood test measures how much fibrinogen is in the
blood. Fibrinogen is a protein that plays a part in blood clotting.Complete blood count (CBC). counting the number of red blood cells
and white blood cells. CBC results cannot diagnose DIC, but they
provide information to help the doctor make a diagnosis.
Blood smear. The number, size, and shape of red blood cells, white
blood cells, and platelets are recorded. Blood cells often look damaged
and abnormal in people with DIC.
-
8/14/2019 Presentation1 OB =0
19/24
Practical markers of disseminated intravascular coagulation
MJ 2003;327:974-977 (25 October), doi:10.1136/bmj.327.7421.974)
-
8/14/2019 Presentation1 OB =0
20/24
Therapeutic Management
Control of the underlying disease: because prolongation of
exposure to the triggering factors worsens DIC, it is
important to eliminate the etiologic factors as rapidly as
possible. Elimination of the cause of DIC can be easily
performed in obstetrics, for example, by cesarean section.
(Bruchim, Y. et al. Disseminated Intravascular Coagulation
(2008)COMPENDIUM Vol. 30,No. 10)
***If not achieved, attempts of using anticoagulation
-
8/14/2019 Presentation1 OB =0
21/24
Management
Prophylactic transfusion of platelets at delivery does not
reduce the incidence of postpartum hemorrhage or
hasten normalization of the platelet count.15 Patients with
DIC should be given fresh frozen plasma and packed red
blood cells.(Padden, M.HELPP Syndrome: Recognition and Perinatal Management
(2008) Compendium Vol30, No10)
Antithrombin Therapy
AT is considered to be the primary inhibitor of circulatingthrombin, and AT levels are considerably reduced in DIC.
-
8/14/2019 Presentation1 OB =0
22/24
Management
ThrombomodulinTherapy may be beneficial in DIC as a sole treatment with no APC transfusion.119
Thrombomodulin had a beneficial effect on coagulation in humans and animals
and appeared to reduce pulmonary vascular injury and leukocyte
accumulation.94,120 These effects were not dependent on thrombomodulins
thrombin-binding properties but were probably mediated through an increase in
APC.94,119
Interleukin-10 and AntiTumor Necrosis Factor Antibodies
Administration of recombinant interleukin-10, an antiinflammatory cytokine, has
been shown to completely nullify the endotoxin-induced effects on coagulation.
(Bruchim, Y. et al. Disseminated Intravascular Coagulation
(2008)COMPENDIUM Vol. 30,No. 10)
-
8/14/2019 Presentation1 OB =0
23/24
Management
Synthetic serine protease inhibitors: continuous infusion of gabexate
mesilate (FOY) or nafamostat mesilate (FUT) is effective for DIC. Controlled
multicenter trials showed a significant improvement not only in clinical
response but also in platelet counts and prothrombin time (PT) in the AT
group compared with the FOY group.
Activated protein C (APC): can inhibit thrombin generation and accelerate
fibrinolytic activity. APC (5,000 to 10,000 units) is administered for 2 days in
patients with placental abruption complicated by DIC. APC is a very safe,
effective, and useful agent for the treatment of DIC.
(Thachil J, Toh CH. Disseminated intravascular coagulation in obstetricdisorders and its acute haematological management. (2001)
-
8/14/2019 Presentation1 OB =0
24/24
Members:Santos, Criselda
Shih, Chun I
Silla, Earica
Sim, Samantha C
Siquijor, Michel Analie V
Solleza, Earl John
Tamayo, James
Tan, Irene CarmelleTauro, Charlene Gayle